NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I think you're probably right, but they should speak for themselves. There would be nothing wrong with a price between $5 and $10, I think we'd all, or nearly all of us, would be nicely ahead.

I believe that the $5 to $10 estimates aren't making the same assumptions that those in the $20's or more are. Perhaps I should have laid down the assumptions to base the estimate on, I could have said we'd have approval by 3rd quarter, perhaps a partnership before approval, or on the other hand I could have said the BLA won't be filed before the 4th quarter. I don't know any of these things, nor do I believe anyone here does, not for certain. I believe that's why we're all over the map, and that's as it should be. I don't want to lay down assumptions, but we'll know much more when the Journal's in, so people can make better refined estimates at that time.

With the Journal and the end of the quiet period there is no telling how much additional guidance the company will provide. We might learn more about their target for submitting the BLA, the status of the FlaskWork effort, etc. All that might tell many people to go higher, or lower.

Gary